Pegasys (Peginterferon Alfa-2A)


Indications and Reactions:

Role Indications Reactions
Secondary
Hepatitis C 84.7%
Chronic Hepatitis C 10.7%
Product Used For Unknown Indication 3.7%
Anxiety 0.3%
Drug Abuse 0.3%
Psychiatric Symptom 0.3%
White Blood Cell Count Decreased 12.9%
Nausea 9.7%
Rash 8.6%
Vomiting 8.6%
Weight Decreased 8.6%
Fatigue 7.5%
Pyrexia 4.3%
Retinal Exudates 4.3%
Adverse Event 3.2%
Haemoglobin Decreased 3.2%
Irritability 3.2%
Malaise 3.2%
Pruritus 3.2%
Rash Pruritic 3.2%
Red Blood Cell Count Decreased 3.2%
Syncope 3.2%
Thrombocytopenia 3.2%
Abdominal Pain Upper 2.2%
Dyspnoea 2.2%
Frustration 2.2%
Concomitant
Hepatitis C 94.1%
Chronic Hepatitis C 4.4%
Hypercholesterolaemia 0.7%
Product Used For Unknown Indication 0.7%
Rash 12.7%
Vomiting 12.7%
Fatigue 10.9%
Rash Pruritic 7.3%
Red Blood Cell Count Decreased 7.3%
Weight Decreased 7.3%
No Therapeutic Response 5.5%
White Blood Cell Count Decreased 5.5%
Diarrhoea 3.6%
Dysgeusia 3.6%
Pain In Extremity 3.6%
Sleep Disorder 3.6%
Stomatitis 3.6%
Anaemia 1.8%
Anaphylactic Reaction 1.8%
Cough 1.8%
Depression 1.8%
Dizziness Postural 1.8%
Drug Ineffective 1.8%
Dry Skin 1.8%

Drug Data